HB1354
To Regulate Pharmacy Benefits Managers; To Amend The Law Concerning The State And Public School Life And Health Insurance Program; And To Amend The Law Concerning Certain Health Benefit Plans.
Last Action (Jan. 31, 2025): Recommended for study in the Interim by the Committee on INSURANCE & COMMERCE- HOUSE
Sponsors
AI-Generated Summary
House Bill 1354 seeks to increase the regulation of Pharmacy Benefits Managers (PBMs) specifically in their dealings with state and public school life and health insurance programs, as well as other government-affiliated health benefit plans. The bill prohibits state entities from entering into contracts with PBMs that utilize 'national' contracts that are not specific to Arkansas law. It establishes minimum reimbursement requirements for pharmacists and pharmacies, ensuring they are paid at least the national average drug acquisition cost or wholesale acquisition cost, plus a professional dispensing fee. Furthermore, the legislation restricts how PBMs charge fees related to drug manufacturer coupons and mandates that any savings from such coupons be passed on to patients or the plan sponsor. The bill also requires pharmaceutical manufacturers to provide rebate rates to state public plans that are equal to or greater than those provided to the Arkansas Medicaid program. Finally, it mandates audits and establishes penalties, including a three-year ban from state contracts, for PBMs found to have engaged in discriminatory or prohibited payment practices.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries of this bill are local Arkansas-based independent pharmacies and pharmacists, who are expected to receive fairer and more consistent reimbursement rates for their services and medication dispensing. Public employees, teachers, and other individuals covered by state-sponsored health plans benefit from requirements that prevent PBMs from inflating costs through coupon-related fees, potentially reducing overall healthcare expenditures. Additionally, state government entities and public school districts that sponsor health plans may benefit from increased transparency in PBM contracting and the requirement for manufacturers to provide higher rebate rates.
Who Might Suffer?
Pharmacy Benefits Managers (PBMs) are the most directly and negatively impacted entities, as the bill significantly limits their operational flexibility, mandates transparent and specific contract terms, and prevents them from utilizing national contract structures that have previously been standard. Large, publicly traded pharmacy chains or entities affiliated with PBMs may face increased regulatory scrutiny and may lose their ability to charge higher rates compared to independent pharmacies. Additionally, pharmaceutical manufacturers may face increased financial obligations due to the requirement to provide state public plans with rebate rates equal to or greater than those negotiated for the state Medicaid program.
Get Notified
Receive an email when this bill's status changes.